Anionic Exchange Membrane water ELectrolysis for highLY efficIenTcy sustAinable, and clean Hydrogen production (AEMELIA)

Horizon Europe Guarantee · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$259,142
Est. Value
February 28, 2027
Response Due
Active
Status

Opportunity Overview

AEMELIA accepts the challenge to design and prototype AEMEL that meets and surpasses Hydrogen Europe’s 2030 targets for performance, durability,safety and cost. AEMELIA proposes a clear path to reach high current-density (1.5 A cm-2) and low voltage (1.75 V). Energy-efficiency surpassesthe 2030 target (46.9 kWh/kg, or 85% of maximum theoretical efficiency), to make 3 times more H2 with less energy compared to XY. LCOH also outshines 2030 targets at 2.5€/kgH2 (17% lower than 2030 target). The degradation rate meets the 2030 target, enabling a 10-year lifetime. These and other KPIs will be validated via the TRL4 prototype of a 5-cell stack at 100 cm² that will deliver 7.2 Nm3/day of H2 at a purity of 99.9% at 15 bar. The team will develop and test disruptive materials, such as fluorine free ionomers; thin, highly-conducting membranes; PGM-free recombination catalysts; and ionomer-free electrodes. These components are based on earth-abundant, safe materials. They would be fully scalable via existing manufacturing processes. They will be combined in innovate cell designs, taking into account novel flow-field design based on CFD models. Innovative operating conditions such as high operating temperature and pulsed current will increase energy-efficiency while reducing balance of plant (BoP) and will be tested in single cells, as will the use of impure water for improved LCA and cost. Lastly, disruptive methods for AI-based ionomer development and the measurement of the catalytically-active surface area of non-PGM catalysts will be developed. Performance, durability, LCA and cost KPIs will be shared with companies to convince them to invest in upscaling after the project. Partners have many success stories in developing disruptive electrochemical materials and systems and bringing them to market. AEMELIA’s market penetration in 2031 is expected to generate 527 M€ in revenues by 2036, and 1172 kt CO2/year avoided compared to steam methane reforming.

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHorizon Europe Guarantee
CountryUnited Kingdom
CategoryResearch Development
Estimated value$259,142
PublishedJanuary 01, 2024
Procurement stageActive solicitation
Response dueFebruary 28, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Heat Indicators for Global Health: Surveillance, Early Warning Systems and adaptation-mitigation actions to reduce heat impacts in pregnant women, infants and health workers in the EU and Africa (HIGH Horizons)
SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION
Support for the International Research Consortium on Animal Health (SIRCAH2)
ZEV-UP: Frugal Zero-Emission Vehicles for the Urban Passenger challenge
Understanding vaccination hesitancy and evaluating single dose and gender-neutral vaccination for improving uptake of HPV vaccines in West and East Africa.
GEORGE
Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival (EChiLiBRiST)
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.